NPCE
Neuropace Inc
NASDAQ: NPCE · HEALTHCARE · MEDICAL DEVICES
$16.86
+1.93% today
Updated 2026-04-30
Market cap
$585.64M
P/E ratio
—
P/S ratio
5.86x
EPS (TTM)
$-0.66
Dividend yield
—
52W range
$8 – $19
Volume
0.2M
Neuropace Inc (NPCE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-21.50%
Operating margin
-6.65%
ROE
-158.70%
ROA
-10.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $36.97M | $-29.97M | 71.58% | -59.59% | -81.07% |
| 2020 | $41.14M | $-24.28M | 73.59% | -31.72% | -59.02% |
| 2021 | $45.18M | $-36.08M | 74.00% | -52.54% | -79.85% |
| 2022 | $45.52M | $-47.08M | 71.38% | -89.62% | -103.43% |
| 2023 | $65.42M | $-32.96M | 73.56% | -41.54% | -50.38% |
| 2024 | $79.91M | $-27.14M | 73.94% | -27.12% | -33.97% |
| 2025 | $99.99M | $-21.46M | 77.23% | -16.34% | -21.47% |